LYKAN BIOSCIENCE
Live / Registered — Registered (as of 15 Feb 2022)
What this means for you
Registered since 15 Feb 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88889833
- Registration number
- 6647204
- Mark type
- Stylized text
- Filed
- 27 Apr 2020
- Published for opposition
- 13 Apr 2021
- Registered
- 15 Feb 2022
- Attorney of record
- Jordan R. Downham
Goods and services
- Class 040 — Treatment of materials: Custom manufacture of pharmaceuticals by pharmaceutical compounders; custom manufacture of chemotherapy drugs by pharmaceutical compounders
Owner
- Lykan Bioscience Holdings, LLC, HOPKINTON, MA, US
- Lykan Bioscience Holdings, LLC, HOPKINTON, MA, US
- Lykan Bioscience Holdings, LLC, HOPKINTON, MA, US
Prosecution history
- 15 Feb 2022 — REGISTERED-PRINCIPAL REGISTER
- 11 Jan 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Jan 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 Dec 2021 — STATEMENT OF USE PROCESSING COMPLETE
- 17 Nov 2021 — USE AMENDMENT FILED
- 15 Dec 2021 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 17 Nov 2021 — TEAS STATEMENT OF USE RECEIVED
- 08 Jun 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 13 Apr 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Apr 2021 — PUBLISHED FOR OPPOSITION
- 24 Mar 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Mar 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Mar 2021 — ATTORNEY REVIEW COMPLETED
- 07 Dec 2020 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 09 Sept 2020 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED